Australian biotech company Novogen has announced the appointments of new board members and a strategic advisor to support its transition into a clinical-stage company with a growing US presence and an investor base in the USA and Australia. 4 March 2014
Executives are moving back to an ‘ex-directory’ world, where smaller, restricted networks are of the highest value, according to RSA, a global life sciences executive search and interim management specialist. 3 March 2014
Australian biotechnology firm Phosphagenics has appointed biotech industry veterans Lawrence Gozlan, Nathan Drona and Geert Cauwenbergh as non-executive directors, with Mr Gozlan assuming the role of Chairman of the Board on an interim basis. 3 March 2014
US biotech firm Biogen Idec has announced today that chairman of the board William Young, known as Bill, will retire from the company’s Board of Directors, effective at the company’s 2014 annual meeting of stockholders. 17 February 2014
Australia-based biotech company Alchemia has announced the appointment of Santo Costa as non-executive chairman of the Board of Directors, effective March 1. 11 February 2014
US biotech firm Chelsea Therapeutics’ (Nasdaq: CHTP) has named Joseph Oliveto as president and chief executive officer and a member of the company's board of directors, effective January 22. 27 January 2014
Merck Serono, the biotech unit of Germany’s Merck KGaA (MRK: DE), has named Steven Hildemann as global chief medical officer and head of global medical and safety for the Merck Serono division. 9 January 2014
US biotech company Promedior has announced that industry veteran William Hodder has joined the company as Vice President of Business Development. 8 January 2014
US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel collaboration to develop DNA-based therapeutics for Friedreich's ataxia, a rare genetic neurodegenerative disease. 1 January 2014
The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik to the Board of Management with the responsibility for innovation and taking over the North America region. 20 December 2013
German biotechnology company Lophius Biosciences GmbH has announced that Dr Robert Phelps has joined the company as director of business operations. 16 December 2013
The France-based biotechnology company Novasep has announced Nadege Laborde as the new president of its industrial biotech business unit. 6 December 2013
With a clear passion for helping patients and a self-confessed need to know everything that is happening "on the shopfloor," Jan-Anders Karlsson is arguably a pharma chief executive like no other, writes TPL's Sophie Flowers after an interview with the man himself. 22 July 2013
Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024